BERKELEY HEIGHTS, N.J., Aug. 28, 2009 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP), ("Cyclacel" or the "Company"), announced that it received a letter on August 24, 2009 from the NASDAQ Listing Qualifications Department notifying the Company that it does not comply with the $10 million minimum stockholders' equity as required by the continued listing requirements of The NASDAQ Global Market set forth in NASDAQ Marketplace Rule 5450(b)(1)(A). NASDAQ's determination was based on a review of the Company's Form 10-Q for the period ended June 30, 2009. At that time the Company's stockholders' equity was reported at approximately $8.2 million.
